France’s Mayoly Spindler Set To Acquire Ipsen’s Consumer Business

Mayoly Spindler is stepping up its presence in the self-care market with the acquisition of Ipsen's Consumer Healthcare business, which has been under strategic review for the past year.

MT1809_Hand Shake_529519042_1200.jpg
• Source: Shuttestock

Laboratoires Mayoly Spindler is taking a significant step towards its goal of becoming a top-10 OTC player in Europe with the acquisition of Ipsen’s Consumer Healthcare business.

Paris, France-based Ipsen has entered into exclusive negotiations with privately held Mayoly Spindler to sell the Consumer Healthcare operation in...

Welcome to HBW Insight

Create an account to read this article

More from Deals

Navamedic To Market OTC Naloxone In Norway Following Switch

 
• By 

Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.

Reckitt Strikes Deal To Sell Essential Home Unit To Focus On CHC, Hygiene

 
• By 

Advent International is poised to take control of Reckitt's Essential Home business, but the UK-based firm will retain a 30% stake.

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

 
• By 

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.

Haleon Takes Full Control Of China JV

 
• By 

Haleon finalizes deal to make its China joint venture a wholly-owned subsidiary in move to "drive category growth in one of the fastest growing OTC markets globally."

More from Business

PharmaSGP Increases Sales Forecast Ahead Of Delisting

 
• By 

German consumer health player expects 2025 sales to be €10m higher than previously forecast after a better than predicted showing in the year-to-date.

Change In P&G’s Helm Coming As Planning For Impact From Tariff Increases In Difficulty

 

Even as CEO Jon Moeller and lead board member Joe Jiminez as well as analysts state confidence the firm’s growth strategy will continue with the executive suite change, the impact of tariff policies could put a dent in its results.

Reckitt Leans On Europe As It Resets Mucinex In US

 
• By 

Decision to reformulate Mucinex sinus products without phenylephrine hits Reckitt's Q2 sales but the firm says it is preparing for upcoming cold & flu season with new marketing push.